Effects of angiotensin type-1 receptor antagonism on small artery function in patients with type 2 diabetes mellitus

Rayaz A. Malik, Ian J. Schofield, Ashley Izzard, Clare Austin, Georgina Bermann, Anthony M. Heagerty

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Endothelial dysfunction has been demonstrated to occur in small arteries from patients with type 2 diabetes and hypertension. The effects of angiotensin II receptor blockade on vessel function were examined using pressure myography in a randomized 12-week double-blind placebo-controlled parallel group study using candesartan cilexitil. The maximal vascular response to acetylcholine (Ach) was impaired at baseline and improved with candesartan. This improvement was primarily caused by an effect in the nitric oxide component of Ach-mediated dilatation. The degree of endothelial dysfunction directly correlated with serum low-density lipoprotein cholesterol levels. Sodium nitroprusside-induced endothelium-independent dilatation was reduced in diabetic patients and intervention with candesartan lead to an improvement in EC50 with no change in maximal response. Vasoconstriction to norepinephrine was normal and did not change with intervention, but responses to angiotensin II were reduced after candesartan in diabetic patients. These results demonstrate that even brief treatment with angiotensin II receptor blockade is associated with a significant improvement in resistance vessel endothelial function.

Original languageEnglish
Pages (from-to)264-269
Number of pages6
JournalHypertension
Volume45
Issue number2
DOIs
Publication statusPublished - Feb 2005
Externally publishedYes

Fingerprint

Angiotensin Type 1 Receptor
Type 2 Diabetes Mellitus
Arteries
Angiotensin Receptors
Acetylcholine
Dilatation
Myography
Nitroprusside
Vasoconstriction
Angiotensin II
LDL Cholesterol
Endothelium
Blood Vessels
Norepinephrine
Nitric Oxide
Placebos
Hypertension
Pressure
candesartan
Serum

Keywords

  • Angiotensin II
  • Arterioles
  • Clinical trials
  • Diabetes mellitus
  • Endothelium
  • Nitric oxide

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Effects of angiotensin type-1 receptor antagonism on small artery function in patients with type 2 diabetes mellitus. / Malik, Rayaz A.; Schofield, Ian J.; Izzard, Ashley; Austin, Clare; Bermann, Georgina; Heagerty, Anthony M.

In: Hypertension, Vol. 45, No. 2, 02.2005, p. 264-269.

Research output: Contribution to journalArticle

Malik, Rayaz A. ; Schofield, Ian J. ; Izzard, Ashley ; Austin, Clare ; Bermann, Georgina ; Heagerty, Anthony M. / Effects of angiotensin type-1 receptor antagonism on small artery function in patients with type 2 diabetes mellitus. In: Hypertension. 2005 ; Vol. 45, No. 2. pp. 264-269.
@article{fed0d3bc769746878976801e3e90a8e4,
title = "Effects of angiotensin type-1 receptor antagonism on small artery function in patients with type 2 diabetes mellitus",
abstract = "Endothelial dysfunction has been demonstrated to occur in small arteries from patients with type 2 diabetes and hypertension. The effects of angiotensin II receptor blockade on vessel function were examined using pressure myography in a randomized 12-week double-blind placebo-controlled parallel group study using candesartan cilexitil. The maximal vascular response to acetylcholine (Ach) was impaired at baseline and improved with candesartan. This improvement was primarily caused by an effect in the nitric oxide component of Ach-mediated dilatation. The degree of endothelial dysfunction directly correlated with serum low-density lipoprotein cholesterol levels. Sodium nitroprusside-induced endothelium-independent dilatation was reduced in diabetic patients and intervention with candesartan lead to an improvement in EC50 with no change in maximal response. Vasoconstriction to norepinephrine was normal and did not change with intervention, but responses to angiotensin II were reduced after candesartan in diabetic patients. These results demonstrate that even brief treatment with angiotensin II receptor blockade is associated with a significant improvement in resistance vessel endothelial function.",
keywords = "Angiotensin II, Arterioles, Clinical trials, Diabetes mellitus, Endothelium, Nitric oxide",
author = "Malik, {Rayaz A.} and Schofield, {Ian J.} and Ashley Izzard and Clare Austin and Georgina Bermann and Heagerty, {Anthony M.}",
year = "2005",
month = "2",
doi = "10.1161/01.HYP.0000153305.50128.a1",
language = "English",
volume = "45",
pages = "264--269",
journal = "Hypertension",
issn = "0194-911X",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Effects of angiotensin type-1 receptor antagonism on small artery function in patients with type 2 diabetes mellitus

AU - Malik, Rayaz A.

AU - Schofield, Ian J.

AU - Izzard, Ashley

AU - Austin, Clare

AU - Bermann, Georgina

AU - Heagerty, Anthony M.

PY - 2005/2

Y1 - 2005/2

N2 - Endothelial dysfunction has been demonstrated to occur in small arteries from patients with type 2 diabetes and hypertension. The effects of angiotensin II receptor blockade on vessel function were examined using pressure myography in a randomized 12-week double-blind placebo-controlled parallel group study using candesartan cilexitil. The maximal vascular response to acetylcholine (Ach) was impaired at baseline and improved with candesartan. This improvement was primarily caused by an effect in the nitric oxide component of Ach-mediated dilatation. The degree of endothelial dysfunction directly correlated with serum low-density lipoprotein cholesterol levels. Sodium nitroprusside-induced endothelium-independent dilatation was reduced in diabetic patients and intervention with candesartan lead to an improvement in EC50 with no change in maximal response. Vasoconstriction to norepinephrine was normal and did not change with intervention, but responses to angiotensin II were reduced after candesartan in diabetic patients. These results demonstrate that even brief treatment with angiotensin II receptor blockade is associated with a significant improvement in resistance vessel endothelial function.

AB - Endothelial dysfunction has been demonstrated to occur in small arteries from patients with type 2 diabetes and hypertension. The effects of angiotensin II receptor blockade on vessel function were examined using pressure myography in a randomized 12-week double-blind placebo-controlled parallel group study using candesartan cilexitil. The maximal vascular response to acetylcholine (Ach) was impaired at baseline and improved with candesartan. This improvement was primarily caused by an effect in the nitric oxide component of Ach-mediated dilatation. The degree of endothelial dysfunction directly correlated with serum low-density lipoprotein cholesterol levels. Sodium nitroprusside-induced endothelium-independent dilatation was reduced in diabetic patients and intervention with candesartan lead to an improvement in EC50 with no change in maximal response. Vasoconstriction to norepinephrine was normal and did not change with intervention, but responses to angiotensin II were reduced after candesartan in diabetic patients. These results demonstrate that even brief treatment with angiotensin II receptor blockade is associated with a significant improvement in resistance vessel endothelial function.

KW - Angiotensin II

KW - Arterioles

KW - Clinical trials

KW - Diabetes mellitus

KW - Endothelium

KW - Nitric oxide

UR - http://www.scopus.com/inward/record.url?scp=13144253079&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13144253079&partnerID=8YFLogxK

U2 - 10.1161/01.HYP.0000153305.50128.a1

DO - 10.1161/01.HYP.0000153305.50128.a1

M3 - Article

VL - 45

SP - 264

EP - 269

JO - Hypertension

JF - Hypertension

SN - 0194-911X

IS - 2

ER -